Hodges is the Enterprise Production editor. Hodges was previously a News reporter.

Meghan Hodges

News

Sports

Arts

Opinion

The Quad

Photo

Video

Illustrations

Cartoons

Graphics

The Stack

PRIME

Enterprise

Interactives

Podcasts

Games

Classifieds

Print issues

Budget Cuts Explained

robots

Sophie Sokolow, an associate professor at the UCLA School of Nursing, said Donezepil has been used to treat patients with mild cognitive impairment. (Wesley Hardin/Daily Bruin)

https://dailybruin.com/2017/03/15/ucla-researcher-discovers-possible-drawback-of-alzheimers-medication/web-ns_-aricept-wh_-jpg/

twitter:card

twitter:description

twitter:title

twitter:site

https://wp.dailybruin.com/images/2017/03/web.ns_.aricept.WH_.jpg

twitter:image

twitter:creator

web.ns.aricept.WH.jpg - Daily Bruin

Science & Health

db-story-ns

Daily Bruin

UCLA researcher discovers possible drawback of Alzheimer&#039;s medication - Daily Bruin

UCLA researcher discovers possible drawback of Alzheimer&#8217;s medication

max-snippet:-1, max-image-preview:large, max-video-preview:-1

A UCLA researcher has found that one of the most commonly prescribed medications for Alzheimer’s disease may accelerate the cognitive decline of patients who carry a genetic variation.

https://dailybruin.com/2017/03/15/ucla-researcher-discovers-possible-drawback-of-alzheimers-medication/

Sunday, March 8, 2026

IN THE NEWS:

UCLA researcher discovers possible drawback of Alzheimer’s medication

By Meghan Hodges

March 15, 2017 9:20 p.m.